
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
By:
Rachel Nania,
AARP En español Published March 24, 2022While Americans brace for a potential bump in COVID-19 cases caused by the spreading BA.2 subvariant of omicron, experts are monitoring another version of the virus — one that’s a hybrid of
both the delta and omicron variants.
What’s being called deltacron informally, and AY.4/BA.1 by scientists, has been detected in a handful of countries, including France, Denmark, Belgium, Germany and the Netherlands. A few
cases have also been reported in the U.S., a preprint study shows.
But despite its infamous parents and splashy name, deltacron — which is really a catchall term for a strain that carries genetic characteristics from both delta and omicron — doesn’t appear
to be a big threat at the moment, experts say. It’s currently circulating “at very low levels,” the World Health Organization’s (WHO) Maria Van Kerkhove said at a recent briefing.
About 75 cases of AY.4/BA.1 have been reported globally, according to GISAID, an international database of viral sequences, so any uptick in infections that’s being registered in Europe and
elsewhere is “very, very unlikely to be coming from any deltacron variant,” says Ross Kedl, a professor of immunology and microbiology at the University of Colorado Anschutz School of
Medicine.
Still, “people are keeping a very close eye on it,” says Richard Kennedy, a professor of medicine and codirector of the Vaccine Research Group at Mayo Clinic.
How a hybrid happensThe emergence of a hybrid variant, also called a recombinant, was not wholly unexpected given the “intense amount of circulation that we saw with both omicron and delta” during winter, Van
Kerkhove said at a recent press briefing. That’s because recombinants occur when two virus strains (in this case, delta and omicron) infect an individual at the same time. As the viruses
replicate they swap information and “the genetic material recombines to create a new strain,” Kedl explains.